Antiviral Drugs Treatment Market Size, Share, Analysis, Trends, Growth Report, 2032
Antiviral Drugs Treatment Market by Drug Class (DNA polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, and Others), by Type (Branded, and Generic), and Application (HIV, Hepatitis, Herpes, Influenza, and Others) – Global Industry Perspective Comprehensive Analysis and Forecast, 2024-2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 51.76 Billion | USD 73.67 Billion | 4.00% | 2023 |
Table Of Content
- Chapter 1. Preface
- 1.1. Report Description and Scope
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
- Chapter 2. Executive Summary
- 2.1. Antiviral Drugs Treatment Market, 2016 - 2026, (USD Billion)
- 2.2. Antiviral Drugs Treatment Market: Snapshot
- Chapter 3. Global Antiviral Drugs Treatment Market – Industry Analysis
- 3.1. Antiviral Drugs Treatment Market: Market Dynamics
- 3.2. Market Drivers
- 3.2.1. Increasing prevalence of viral infections
- 3.2.2. Rise in R&D activities and development of newer & advanced formulations
- 3.3. Restraints
- 3.3.1. Increasing preventive measures and awareness about the availability of vaccines for viral infections
- 3.4. Opportunity
- 3.4.1. Growth opportunities in the emerging economies
- 3.5. Porter’s Five Forces Analysis
- 3.6. Market Attractiveness Analysis
- 3.6.1. Market attractiveness analysis by Drug Class segment
- 3.6.2. Market attractiveness analysis by Type
- 3.6.3. Market attractiveness analysis by Application segment
- 3.6.4. Market attractiveness analysis by regional segment
- Chapter 4. Global Antiviral Drugs Treatment Market - Competitive Landscape
- 4.1. Company market share analysis
- 4.1.1. Global Antiviral Drugs Treatment market: company market share analysis, 2018
- 4.2. Strategic development
- 4.2.1. Acquisitions & mergers
- 4.2.2. New Drug Class launches
- 4.2.3. Agreements, partnerships, cullaborations and joint ventures
- 4.2.4. Research and development and regional expansion
- 4.1. Company market share analysis
- Chapter 5. Global Antiviral Drugs Treatment Market – Drug Class Segment Analysis
- 5.1. Global Antiviral Drugs Treatment market overview: by Drug Class
- 5.1.1. Global Antiviral Drugs Treatment market revenue share, by Drug Class, 2019 and 2026
- 5.2. DNA Pulymerase Inhibitors
- 5.3. Global Antiviral Drugs Treatment market by DNA Pulymerase Inhibitors, 2016-2026 (USD Billion)
- 5.4. Reverse Transcriptase Inhibitors
- 5.4.1. Global Antiviral Drugs Treatment market by Reverse Transcriptase Inhibitors, 2016-2026 (USD Billion)
- 5.5. Protease Inhibitors
- 5.5.1. Global Antiviral Drugs Treatment market by Protease Inhibitors, 2016-2026 (USD Billion)
- 5.6. Neuraminidase Inhibitors
- 5.6.1. Global Antiviral Drugs Treatment market by Neuraminidase Inhibitors, 2016-2026 (USD Billion)
- 5.7. Others
- 5.7.1. Global Antiviral Drugs Treatment market by Others, 2016-2026 (USD Billion)
- 5.1. Global Antiviral Drugs Treatment market overview: by Drug Class
- Chapter 6. Global Antiviral Drugs Treatment Market – Type Segment Analysis
- 6.1. Global Antiviral Drugs Treatment market overview: by Type
- 6.1.1. Global Antiviral Drugs Treatment market revenue share, by Type , 2019 and 2026
- 6.2. Growth Factors
- 6.2.1. Global Antiviral Drugs Treatment market by Growth Factors, 2016-2026 (USD Billion)
- 6.3. Branded
- 6.3.1. Global Antiviral Drugs Treatment market by Branded, 2016-2026 (USD Billion)
- 6.4. Generic
- 6.4.1. Global Antiviral Drugs Treatment market by Generic, 2016-2026 (USD Billion)
- 6.1. Global Antiviral Drugs Treatment market overview: by Type
- Chapter 7. Global Antiviral Drugs Treatment Market – Application Segment Analysis
- 7.1. Global Antiviral Drugs Treatment market overview: by Application
- 7.1.1. Global Antiviral Drugs Treatment market revenue share, by Application, 2019 and 2026
- 7.2. HIV
- 7.2.1. Global Antiviral Drugs Treatment market by HIV, 2016-2026 (USD Billion)
- 7.3. Hepatitis
- 7.3.1. Global Antiviral Drugs Treatment market by Hepatitis, 2016-2026 (USD Billion)
- 7.4. Herpes
- 7.4.1. Global Antiviral Drugs Treatment market by Herpes, 2016-2026 (USD Billion)
- 7.5. Influenza
- 7.5.1. Global Antiviral Drugs Treatment market by Influenza, 2016-2026 (USD Billion)
- 7.6. Others
- 7.6.1. Global Antiviral Drugs Treatment market by Others, 2016-2026 (USD Billion)
- 7.1. Global Antiviral Drugs Treatment market overview: by Application
- Chapter 8. Global Antiviral Drugs Treatment Market - Regional Analysis
- 8.1. Global Antiviral Drugs Treatment market overview: by region
- 8.1.1. Global Antiviral Drugs Treatment market revenue share, by region, 2019 and 2026
- 8.2. North America
- 8.2.1. North America Antiviral Drugs Treatment market, by country, 2016-2026 (USD Billion)
- 8.2.2. North America Antiviral Drugs Treatment market revenue, by Drug Class, 2016-2026 (USD Billion)
- 8.2.3. North America Antiviral Drugs Treatment market revenue, by Type , 2016-2026 (USD Billion)
- 8.2.4. North America Antiviral Drugs Treatment market revenue, by Application, 2016-2026 (USD Billion)
- 8.2.5. The U.S.
- 8.2.5.1. The U.S. Antiviral Drugs Treatment market revenue, by Drug Class, 2016-2026 (USD Billion)
- 8.2.5.2. The U.S. Antiviral Drugs Treatment market revenue, by Type , 2016-2026 (USD Billion)
- 8.2.5.3. The U.S. Antiviral Drugs Treatment market revenue, by Application, 2016-2026 (USD Billion)
- 8.2.6. Rest of North America
- 8.2.6.1. Rest of North America Antiviral Drugs Treatment market revenue, by Drug Class, 2016-2026 (USD Billion)
- 8.2.6.2. Rest of North America Antiviral Drugs Treatment market revenue, by Type , 2016-2026 (USD Billion)
- 8.2.6.3. Rest of North America Antiviral Drugs Treatment market revenue, by Application, 2016-2026 (USD Billion)
- 8.3. Europe
- 8.3.1. Europe Antiviral Drugs Treatment market, by country, 2016-2026 (USD Billion)
- 8.3.2. Europe Antiviral Drugs Treatment market revenue, by Drug Class, 2016-2026 (USD Billion)
- 8.3.3. Europe Antiviral Drugs Treatment market revenue, by Type , 2016-2026 (USD Billion)
- 8.3.4. Europe Antiviral Drugs Treatment market revenue, by Application, 2016-2026 (USD Billion)
- 8.3.5. U.K.
- 8.3.5.1. U.K. Antiviral Drugs Treatment market revenue, by Drug Class, 2016-2026 (USD Billion)
- 8.3.5.2. U.K. Antiviral Drugs Treatment market revenue, by Type , 2016-2026 (USD Billion)
- 8.3.5.3. U.K. Antiviral Drugs Treatment market revenue, by Application, 2016-2026 (USD Billion)
- 8.3.6. France
- 8.3.6.1. France Antiviral Drugs Treatment market revenue, by Drug Class, 2016-2026 (USD Billion)
- 8.3.6.2. France Antiviral Drugs Treatment market revenue, by Type , 2016-2026 (USD Billion)
- 8.3.6.3. France Antiviral Drugs Treatment market revenue, by Application, 2016-2026 (USD Billion)
- 8.3.7. Germany
- 8.3.7.1. Germany Antiviral Drugs Treatment market revenue, by Drug Class, 2016-2026 (USD Billion)
- 8.3.7.2. Germany Antiviral Drugs Treatment market revenue, by Type , 2016-2026 (USD Billion)
- 8.3.7.3. Germany Antiviral Drugs Treatment market revenue, by Application, 2016-2026 (USD Billion)
- 8.3.8. Rest of Europe
- 8.3.8.1. Rest of Europe Antiviral Drugs Treatment market revenue, by Drug Class, 2016-2026 (USD Billion)
- 8.3.8.2. Rest of Europe Antiviral Drugs Treatment market revenue, by Type , 2016-2026 (USD Billion)
- 8.3.8.3. Rest of Europe Antiviral Drugs Treatment market revenue, by Application, 2016-2026 (USD Billion)
- 8.4. Asia Pacific
- 8.4.1. Asia Pacific Antiviral Drugs Treatment market, by country, 2016-2026 (USD Billion)
- 8.4.2. Asia Pacific Antiviral Drugs Treatment market revenue, by Drug Class, 2016-2026 (USD Billion)
- 8.4.3. Asia Pacific Antiviral Drugs Treatment market revenue, by Type , 2016-2026 (USD Billion)
- 8.4.4. Asia Pacific Antiviral Drugs Treatment market revenue, by Application, 2016-2026 (USD Billion)
- 8.4.5. China
- 8.4.5.1. China Antiviral Drugs Treatment market revenue, by Drug Class, 2016-2026 (USD Billion)
- 8.4.5.2. China Antiviral Drugs Treatment market revenue, by Type , 2016-2026 (USD Billion)
- 8.4.5.3. China Antiviral Drugs Treatment market revenue, by Application, 2016-2026 (USD Billion)
- 8.4.6. Japan
- 8.4.6.1. Japan Antiviral Drugs Treatment market revenue, by Drug Class, 2016-2026 (USD Billion)
- 8.4.6.2. Japan Antiviral Drugs Treatment market revenue, by Type , 2016-2026 (USD Billion)
- 8.4.6.3. Japan Antiviral Drugs Treatment market revenue, by Application, 2016-2026 (USD Billion)
- 8.4.7. India
- 8.4.7.1. India Antiviral Drugs Treatment market revenue, by Drug Class, 2016-2026 (USD Billion)
- 8.4.7.2. India Antiviral Drugs Treatment market revenue, by Type , 2016-2026 (USD Billion)
- 8.4.7.3. India Antiviral Drugs Treatment market revenue, by Application, 2016-2026 (USD Billion)
- 8.4.8. Rest of Asia Pacific
- 8.4.8.1. Rest of Asia Pacific Antiviral Drugs Treatment market revenue, by Drug Class, 2016-2026 (USD Billion)
- 8.4.8.2. Rest of Asia Pacific Antiviral Drugs Treatment market revenue, by Type , 2016-2026 (USD Billion)
- 8.4.8.3. Rest of Asia Pacific Antiviral Drugs Treatment market revenue, by Application, 2016-2026 (USD Billion)
- 8.5. Latin America
- 8.5.1. Latin America Antiviral Drugs Treatment market, by country, 2016-2026 (USD Billion)
- 8.5.2. Latin America Antiviral Drugs Treatment market revenue, by Drug Class, 2016-2026 (USD Billion)
- 8.5.3. Latin America Antiviral Drugs Treatment market revenue, by Type , 2016-2026 (USD Billion)
- 8.5.4. Latin America Antiviral Drugs Treatment market revenue, by Application, 2016-2026 (USD Billion)
- 8.5.5. Brazil
- 8.5.5.1. Brazil Antiviral Drugs Treatment market revenue, by Drug Class, 2016-2026 (USD Billion)
- 8.5.5.2. Brazil Antiviral Drugs Treatment market revenue, by Type , 2016-2026 (USD Billion)
- 8.5.5.3. Brazil Antiviral Drugs Treatment market revenue, by Application, 2016-2026 (USD Billion)
- 8.5.6. Rest of Latin America
- 8.5.6.1. Rest of Latin America Antiviral Drugs Treatment market revenue, by Drug Class, 2016-2026 (USD Billion)
- 8.5.6.2. Rest of Latin America Antiviral Drugs Treatment market revenue, by Type , 2016-2026 (USD Billion)
- 8.5.6.3. Rest of Latin America Antiviral Drugs Treatment market revenue, by Application, 2016-2026 (USD Billion)
- 8.6. Middle East & Africa
- 8.6.1. Middle East & Africa Antiviral Drugs Treatment market, 2016-2026 (USD Billion)
- 8.6.2. Middle East & Africa Antiviral Drugs Treatment market revenue, by Drug Class, 2016-2026 (USD Billion)
- 8.6.3. Middle East & Africa Antiviral Drugs Treatment market revenue, by Type , 2016-2026 (USD Billion)
- 8.6.4. Middle East & Africa Antiviral Drugs Treatment market revenue, by Application, 2016-2026 (USD Billion)
- 8.1. Global Antiviral Drugs Treatment market overview: by region
- Chapter 9. Company Profiles
- 9.1. Gilead Sciences.
- 9.1.1. Overview
- 9.1.2. Financials
- 9.1.3. Product Portfolio
- 9.1.4. Business Strategy
- 9.1.5. Recent Developments
- 9.2. F. Hoffmann-La Roche AG
- 9.2.1. Overview
- 9.2.2. Financials
- 9.2.3. Product Portfolio
- 9.2.4. Business Strategy
- 9.2.5. Recent Developments
- 9.3. GlaxoSmithKline plc.
- 9.3.1. Overview
- 9.3.2. Financials
- 9.3.3. Product Portfolio
- 9.3.4. Business Strategy
- 9.3.5. Recent Developments
- 9.4. AbbVie
- 9.4.1. Overview
- 9.4.2. Financials
- 9.4.3. Product Portfolio
- 9.4.4. Business Strategy
- 9.4.5. Recent Developments
- 9.5. Merck & Co., Inc
- 9.5.1. Overview
- 9.5.2. Financials
- 9.5.3. Product Portfolio
- 9.5.4. Business Strategy
- 9.5.5. Recent Developments
- 9.6. Johnson & Johnson Services , Inc
- 9.6.1. Overview
- 9.6.2. Financials
- 9.6.3. Product Portfolio
- 9.6.4. Business Strategy
- 9.6.5. Recent Developments
- 9.7. Bristul-Myers Squibb Company
- 9.7.1. Overview
- 9.7.2. Financials
- 9.7.3. Product Portfolio
- 9.7.4. Business Strategy
- 9.7.5. Recent Developments
- 9.8. Cipla Inc.
- 9.8.1. Overview
- 9.8.2. Financials
- 9.8.3. Product Portfolio
- 9.8.4. Business Strategy
- 9.8.5. Recent Developments
- 9.9. Aurobindo Pharma
- 9.9.1. Overview
- 9.9.2. Financials
- 9.9.3. Product Portfolio
- 9.9.4. Business Strategy
- 9.9.5. Recent Developments
- 9.10. Dr. Reddy’s Laboratories Ltd.
- 9.10.1. Overview
- 9.10.2. Financials
- 9.10.3. Product Portfolio
- 9.10.4. Business Strategy
- 9.10.5. Recent Developments
- 9.1. Gilead Sciences.
Table Of Figures
List of Figures
1. Market research process
2. Market research methodology
3. Global Antiviral Drugs Treatment market, 2016-2026 (USD Billion)
4. Porter’s five forces analysis: Antiviral Drugs Treatment market
5. Global Antiviral Drugs Treatment market attractiveness, by Drug Class
6. Global Antiviral Drugs Treatment market attractiveness, by Type
7. Global Antiviral Drugs Treatment market attractiveness, by Application
8. Global Antiviral Drugs Treatment market revenue share, by Drug Class, 2019 and 2026
9. Global Antiviral Drugs Treatment market by DNA Polymerase Inhibitors, 2016-2026 (USD Billion)
10. Global Antiviral Drugs Treatment market by Reverse Transcriptase Inhibitors, 2016-2026 (USD Billion)
11. Global Antiviral Drugs Treatment market by Protease Inhibitors, 2016-2026 (USD Billion)
12. Global Antiviral Drugs Treatment market by Neuraminidase Inhibitors, 2016-2026 (USD Billion)
13. Global Antiviral Drugs Treatment market by Others, 2016-2026 (USD Billion)
14. Global Antiviral Drugs Treatment market revenue share, by Type , 2019 and 2026
15. Global Antiviral Drugs Treatment market by Growth Factors, 2016-2026 (USD Billion)
16. Global Antiviral Drugs Treatment market by Branded, 2016-2026 (USD Billion)
17. Global Antiviral Drugs Treatment market by Generic, 2016-2026 (USD Billion)
18. Global Antiviral Drugs Treatment market revenue share, by Application, 2019 and 2026
19. Global Antiviral Drugs Treatment market by HIV, 2016-2026 (USD Billion)
20. Global Antiviral Drugs Treatment market by Hepatitis, 2016-2026 (USD Billion)
21. Global Antiviral Drugs Treatment market by Herpes, 2016-2026 (USD Billion)
22. Global Antiviral Drugs Treatment market by Influenza, 2016-2026 (USD Billion)
23. Global Antiviral Drugs Treatment market by others, 2016-2026 (USD Billion)
24. Global Antiviral Drugs Treatment market revenue share, by region, 2018 & 2025
25. North America Antiviral Drugs Treatment market, 2016-2026 (USD Billion)
26. Europe Antiviral Drugs Treatment market, 2016-2026 (USD Billion)
27. Asia Pacific Antiviral Drugs Treatment market, 2016-2026 (USD Billion)
28. Latin America Antiviral Drugs Treatment market, 2016-2026 (USD Billion)
29. Middle East & Africa Antiviral Drugs Treatment market, 2016-2026 (USD Billion)
Table Of Tables
List of Tables
1. Global Antiviral Drugs Treatment market: snapshot
2. Drivers for Antiviral Drugs Treatment market: impact analysis
3. Restraints for Antiviral Drugs Treatment market: impact analysis
4. North America Antiviral Drugs Treatment market revenue, by country, 2016-2026 (USD Billion)
5. North America Antiviral Drugs Treatment market revenue, by Drug Class, 2016-2026 (USD Billion)
6. North America Antiviral Drugs Treatment market revenue, by Type , 2016-2026 (USD Billion)
7. North America Antiviral Drugs Treatment market revenue, by Application, 2016-2026 (USD Billion)
8. The U.S. Antiviral Drugs Treatment market revenue, by Drug Class, 2016-2026 (USD Billion)
9. The U.S. Antiviral Drugs Treatment market revenue, by Type , 2016-2026 (USD Billion)
10. The U.S. Antiviral Drugs Treatment market revenue, by Application, 2016-2026 (USD Billion)
11. Rest of North America Antiviral Drugs Treatment market revenue, by Drug Class, 2016-2026 (USD Billion)
12. Rest of North America Antiviral Drugs Treatment market revenue, by Type , 2016-2026 (USD Billion)
13. Rest of North America Antiviral Drugs Treatment market revenue, by Application, 2016-2026 (USD Billion)
14. Europe Antiviral Drugs Treatment market revenue, by country, 2016-2026 (USD Billion)
15. Europe Antiviral Drugs Treatment market revenue, by Drug Class, 2016-2026 (USD Billion)
16. Europe Antiviral Drugs Treatment market revenue, by Type , 2016-2026 (USD Billion)
17. Europe Antiviral Drugs Treatment market revenue, by Application, 2016-2026 (USD Billion)
18. U.K. Antiviral Drugs Treatment market revenue, by Drug Class, 2016-2026 (USD Billion)
19. U.K. Antiviral Drugs Treatment market revenue, by Type , 2016-2026 (USD Billion)
20. U.K. Antiviral Drugs Treatment market revenue, by Application, 2016-2026 (USD Billion)
21. France Antiviral Drugs Treatment market revenue, by Drug Class, 2016-2026 (USD Billion)
22. France Antiviral Drugs Treatment market revenue, by Type , 2016-2026 (USD Billion)
23. France Antiviral Drugs Treatment market revenue, by Application, 2016-2026 (USD Billion)
24. Germany Antiviral Drugs Treatment market revenue, by Drug Class, 2016-2026 (USD Billion)
25. Germany Antiviral Drugs Treatment market revenue, by Type , 2016-2026 (USD Billion)
26. Germany Antiviral Drugs Treatment market revenue, by Application, 2016-2026 (USD Billion)
27. Rest of Europe Antiviral Drugs Treatment market revenue, by Drug Class, 2016-2026 (USD Billion)
28. Rest of Europe Antiviral Drugs Treatment market revenue, by Type , 2016-2026 (USD Billion)
29. Rest of Europe Antiviral Drugs Treatment market revenue, by Type , 2016-2026 (USD Billion)
30. Rest of Europe Antiviral Drugs Treatment market revenue, by Application, 2016-2026 (USD Billion)
31. Asia Pacific Antiviral Drugs Treatment market revenue, by country, 2016-2026 (USD Billion)
32. Asia Pacific Antiviral Drugs Treatment market revenue, by Drug Class, 2016-2026 (USD Billion)
33. Asia Pacific Antiviral Drugs Treatment market revenue, by Type , 2016-2026 (USD Billion)
34. Asia Pacific Antiviral Drugs Treatment market revenue, by Application, 2016-2026 (USD Billion)
35. China Antiviral Drugs Treatment market revenue, by Drug Class, 2016-2026 (USD Billion)
36. China Antiviral Drugs Treatment market revenue, by Type , 2016-2026 (USD Billion)
37. China Antiviral Drugs Treatment market revenue, by Application, 2016-2026 (USD Billion)
38. Japan Antiviral Drugs Treatment market revenue, by Drug Class, 2016-2026 (USD Billion)
39. Japan Antiviral Drugs Treatment market revenue, by Type , 2016-2026 (USD Billion)
40. Japan Antiviral Drugs Treatment market revenue, by Application, 2016-2026 (USD Billion)
41. India Antiviral Drugs Treatment market revenue, by Drug Class, 2016-2026 (USD Billion)
42. India Antiviral Drugs Treatment market revenue, by Type , 2016-2026 (USD Billion)
43. India Antiviral Drugs Treatment market revenue, by Application, 2016-2026 (USD Billion)
44. Rest of Asia Pacific Antiviral Drugs Treatment market revenue, by Drug Class, 2016-2026 (USD Billion)
45. Rest of Asia Pacific Antiviral Drugs Treatment market revenue, by Type , 2016-2026 (USD Billion)
46. Rest of Asia Pacific Antiviral Drugs Treatment market revenue, by Application, 2016-2026 (USD Billion)
47. Latin America Antiviral Drugs Treatment market revenue, by country, 2016-2026 (USD Billion)
48. Latin America Antiviral Drugs Treatment market revenue, by Type , 2016-2026 (USD Billion)
49. Latin America Antiviral Drugs Treatment market revenue, by Drug Class, 2016-2026 (USD Billion)
50. Latin America Antiviral Drugs Treatment market revenue, by Application, 2016-2026 (USD Billion)
51. Brazil Antiviral Drugs Treatment market revenue, by Drug Class, 2016-2026 (USD Billion)
52. Brazil Antiviral Drugs Treatment market revenue, by Type , 2016-2026 (USD Billion)
53. Brazil Antiviral Drugs Treatment market revenue, by Application, 2016-2026 (USD Billion)
54. Rest of Latin America Antiviral Drugs Treatment market revenue, by Drug Class, 2016-2026 (USD Billion)
55. Rest of Latin America Antiviral Drugs Treatment market revenue, by Type , 2016-2026 (USD Billion)
56. Rest of Latin America Antiviral Drugs Treatment market revenue, by Application, 2016-2026 (USD Billion)
57. Middle East & Africa Antiviral Drugs Treatment market revenue, by Drug Class, 2016-2026 (USD Billion)
58. Middle East & Africa Antiviral Drugs Treatment market revenue, by Type , 2016-2026 (USD Billion)
59. Middle East & Africa Antiviral Drugs Treatment market revenue, by Application, 2016-2026 (USD Billion)
Methodology
FrequentlyAsked Questions
Antiviral drug treatment involves the use of pharmaceuticals that are designed to target and prevent the growth and spread of viruses within the body. These treatments are also known as antiviral agents. Antiviral medications have been designed specifically to treat viral infections, which are caused by viruses, which are microscopic infectious agents that can cause a wide range of disorders.
The demand for antiviral medications is driven in a direct manner by the prevalence of viral illnesses such as HIV, influenza, and hepatitis, as well as new viruses (such as COVID-19). The growth of the market is aided by the rising prevalence of infectious diseases caused by viruses.
The Global Antiviral Drugs Treatment Market size was worth around USD 51.76 Billion in 2023 and is predicted to grow to around USD 73.67 Billion by 2032 with a compound annual growth rate (CAGR) of roughly 4.00% between 2024 and 2032
North America held largest revenue share of the global Antiviral Drugs Treatment market in 2019. This is attributed to the existence of key players in the region, accessibility of sophisticated healthcare infrastructure, and cumulative consciousness of viral diseases.
Major players in Antiviral Drugs Treatment market are Gilead Sciences; F. Hoffmann-La Roche AG; GlaxoSmithKline plc; AbbVie; Merck & Co., Inc.; Johnson & Johnson Services, Inc.; Bristol-Myers Squibb Company; Cipla Inc.; Aurobindo Pharma; and Dr. Reddy’s Laboratories Ltd. & Co., Inc.
Choose License Type
RelatedNews
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed